The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-methoxybenzylidene)-2-phenyl-3-(pyridin-3-yl)-1,2-dihydro-1,2,4-triazin-6(5H)-one ID: ALA4865603
PubChem CID: 155809809
Max Phase: Preclinical
Molecular Formula: C22H18N4O2
Molecular Weight: 370.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C=C2\N=C(c3cccnc3)N(c3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C22H18N4O2/c1-28-19-11-9-16(10-12-19)14-20-22(27)25-26(18-7-3-2-4-8-18)21(24-20)17-6-5-13-23-15-17/h2-15H,1H3,(H,25,27)/b20-14-
Standard InChI Key: BNAKUNINWOCARC-ZHZULCJRSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
28.0789 -3.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0789 -4.3832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7909 -4.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5029 -4.3832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5029 -3.5583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7909 -3.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7909 -2.3166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3632 -3.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6499 -3.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9349 -3.1490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2220 -3.5629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2241 -4.3887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9448 -4.7990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6546 -4.3826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5113 -4.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7952 -4.3947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2168 -4.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7909 -5.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0743 -6.0277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0740 -6.8519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7890 -7.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5058 -6.8482 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5026 -6.0254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2123 -5.6218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9254 -6.0353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6414 -5.6238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6399 -4.7945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9264 -4.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
1 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
4 17 1 0
3 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
17 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 17 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.41Molecular Weight (Monoisotopic): 370.1430AlogP: 3.43#Rotatable Bonds: 4Polar Surface Area: 66.82Molecular Species: ACIDHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.40CX Basic pKa: 3.04CX LogP: 2.77CX LogD: 2.02Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -0.97
References 1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H.. (2021) Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition., 219 [PMID:33892270 ] [10.1016/j.ejmech.2021.113457 ]